Benjamin Israelow
- Molecular Biology
- Infectious Diseases top 2%
- Epidemiology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Co-authors
- Matthew J. EvansAkiko IwasakiTianyang MaoMarion SourisseauRobert HomerBrian D. BrownHuiping DongGavriel Mullokandov
- Topics
- SARS-CoV-2 and COVID-19 Research (6 papers)Hepatitis C virus research (6 papers)COVID-19 Clinical Research Studies (4 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Benjamin Israelow
15 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 585
- Infectious Diseases 556
- Epidemiology 320
- Cancer Research 320
- Immunology 295
Countries citing papers authored by Benjamin Israelow
This map shows the geographic impact of Benjamin Israelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Israelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Israelow more than expected).
Fields of papers citing papers by Benjamin Israelow
This network shows the impact of papers produced by Benjamin Israelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Israelow. The network helps show where Benjamin Israelow may publish in the future.
Co-authorship network of co-authors of Benjamin Israelow
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Israelow. A scholar is included among the top collaborators of Benjamin Israelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Israelow. Benjamin Israelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Polymer nanoparticles deliver mRNA to the lung for mucosal vaccinationbreakdown → | 107 |
| 3 | Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecovirusesbreakdown → | 209 |
| 4 | 70 | |
| 5 | 11 | |
| 6 | 103 | |
| 7 | 270 | |
| 8 | 27 | |
| 9 | 21 | |
| 10 | 54 | |
| 11 | 57 | |
| 12 | 59 | |
| 13 | 315 | |
| 14 | 108 | |
| 15 | 44 |
About Benjamin Israelow
Benjamin Israelow is a scholar working on Hepatology, Infectious Diseases and Cancer Research, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Hepatitis C virus research (6 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Hepatology (257 citations), Infectious Diseases (556 citations) and Cancer Research (320 citations). Benjamin Israelow has collaborated with scholars based in United States and France. Frequent co-authors include Matthew J. Evans, Akiko Iwasaki, Tianyang Mao, Marion Sourisseau, Robert Homer, Brian D. Brown, Huiping Dong, Gavriel Mullokandov, Eric Song and Alessia Baccarini. Their work appears in journals such as Science, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.